Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-817399 in RA with Inadequate Response to Methotrexate
NCT01404585Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of BMS-817399 in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Sep 2011; status: completed.
02
Drugs
BMS-817399
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01404585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404585.